1. Home
  2. BCDA vs BHAT Comparison

BCDA vs BHAT Comparison

Compare BCDA & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCDA
  • BHAT
  • Stock Information
  • Founded
  • BCDA N/A
  • BHAT 2010
  • Country
  • BCDA United States
  • BHAT China
  • Employees
  • BCDA N/A
  • BHAT N/A
  • Industry
  • BCDA Biotechnology: Pharmaceutical Preparations
  • BHAT Recreational Games/Products/Toys
  • Sector
  • BCDA Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • BCDA Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • BCDA 10.1M
  • BHAT 10.3M
  • IPO Year
  • BCDA N/A
  • BHAT 2019
  • Fundamental
  • Price
  • BCDA $2.35
  • BHAT $1.87
  • Analyst Decision
  • BCDA Strong Buy
  • BHAT
  • Analyst Count
  • BCDA 1
  • BHAT 0
  • Target Price
  • BCDA $25.00
  • BHAT N/A
  • AVG Volume (30 Days)
  • BCDA 238.1K
  • BHAT 167.3K
  • Earning Date
  • BCDA 08-12-2025
  • BHAT 04-30-2025
  • Dividend Yield
  • BCDA N/A
  • BHAT N/A
  • EPS Growth
  • BCDA N/A
  • BHAT N/A
  • EPS
  • BCDA N/A
  • BHAT N/A
  • Revenue
  • BCDA $3,000.00
  • BHAT $18,724,190.00
  • Revenue This Year
  • BCDA N/A
  • BHAT N/A
  • Revenue Next Year
  • BCDA N/A
  • BHAT N/A
  • P/E Ratio
  • BCDA N/A
  • BHAT N/A
  • Revenue Growth
  • BCDA N/A
  • BHAT N/A
  • 52 Week Low
  • BCDA $1.63
  • BHAT $1.61
  • 52 Week High
  • BCDA $4.66
  • BHAT $101.00
  • Technical
  • Relative Strength Index (RSI)
  • BCDA 54.75
  • BHAT 52.79
  • Support Level
  • BCDA $2.22
  • BHAT $1.82
  • Resistance Level
  • BCDA $2.42
  • BHAT $1.95
  • Average True Range (ATR)
  • BCDA 0.13
  • BHAT 0.10
  • MACD
  • BCDA 0.01
  • BHAT 0.01
  • Stochastic Oscillator
  • BCDA 72.97
  • BHAT 52.78

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is a producer, developer, and operator of augmented reality (AR) interactive entertainment games and toys in China, including interactive educational materials, mobile games, and toys with mobile game features. The company's products include AR Racer, AR Crazy Bug, AR 3D Magic Box, AR Dinosaur, Talking Tom and Friends Bouncing Bubble, and Immersive Education Classes. The company reports in the following segments: Interactive toys - animation series, Interactive toys - game series, and Mobile games, Information services, and Communication services, out of which the majority of the revenue is generated from the game series. The majority of its revenues are generated in China.

Share on Social Networks: